Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

SHE:002773 Revenue

Chengdu Kanghong Pharmaceutical Group had revenue of 992.42M CNY in the quarter ending September 30, 2026, a decrease of -15.19%. This brings the company's total for the last twelve months to 4.13B, down -11.41% year-over-year. In the year 2025, Chengdu Kanghong Pharmaceutical Group had annual revenue of 4.59B with 2.98% growth. That makes Chengdu Kanghong Pharmaceutical Group the 10,021st largest company in the world by revenue and 1,633rd in China.

• Revenue (ttm): 4.13B
• Revenue Growth: -11.41%
• P/S Ratio: 4.19
• Revenue / Employee: 924.57K
• Employees: 4,470
• Market Cap: 17.32B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Manufacturing 4.58B 100.0%
• Unallocated Other Business 1.88M 0.0%

By Geography

Chart

• East China 1.24B 27.0%
• South China 1.14B 24.9%
• Southwest China 834.20M 18.2%
• North China 606.94M 13.2%
• Northwest China 410.54M 9.0%
• Northeast China 352.46M 7.7%
• Unallocated 1.88M 0.0%
• Overseas 478.88K 0.0%

Fiscal year ended Dec 31, 2025 See the full SHE:002773 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	4.59B	132.48M	2.98%
Dec 31, 2024	4.45B	495.20M	12.51%
Dec 31, 2023	3.96B	568.43M	16.77%
Jan 1, 2023	3.39B	-216.32M	-6.00%
Jan 1, 2022	3.61B	309.92M	9.40%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 31, 2026

Data Sources Report a data error